Does ENZALUTAMIDE Cause Hepatic function abnormal? 124 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Hepatic function abnormal have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.3% of all adverse event reports for ENZALUTAMIDE.
124
Reports of Hepatic function abnormal with ENZALUTAMIDE
0.3%
of all ENZALUTAMIDE reports
28
Deaths
50
Hospitalizations
How Dangerous Is Hepatic function abnormal From ENZALUTAMIDE?
Of the 124 reports, 28 (22.6%) resulted in death, 50 (40.3%) required hospitalization, and 4 (3.2%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 124 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which ENZALUTAMIDE Alternatives Have Lower Hepatic function abnormal Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE